Skip to search formSkip to main contentSkip to account menu

AKN -028

Known as: AKN-028, FLT3/KIT Kinase Inhibitor AKN-028 
An orally bioavailable protein tyrosine kinase inhibitor for FMS-related tyrosine kinase 3 (FLT3; STK1) and stem cell factor receptor (SCFR; KIT… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Aims: Pulmonary arterial hypertension (PAH) is a disease characterized by an increase in pulmonary vascular resistance and right… 
2016
2016
Introduction The CysF9[93]β sulfhydryl group of haemoglobin is invariant in all animals but in fish and amphibian hemoglobin’s [1… 
2015
2015
ABSTRAK Hernani Maryulianti NIM : S4311027 DETERMINASI KUALITAS AUDIT DAN PENGARUHNYA TERHADAP FRAUD DETECTION PADA LAPORAN… 
2015
2015
Cite this article: Alencar AKN, Barreiro EJ, Sudo RT, Zapata-Sudo G (2014) Adenosine A2A Receptor as a Target of Treatment for… 
2012
2012
Aberrantly expressed tyrosine kinases have emerged as promising targets for drug development in acute myeloid leukemia (AML). We… 
2012
2012
Acute myeloid leukemia (AML) is a life-threatening malignant disorder with dismal prognosis. AML is characterized by frequent… 
2010
2010
Abstract 1837 AKN-028 (formerly BVT-II, abstract presented at EHA 2008, Eriksson A et al) is a tyrosine kinase inhibitor… 
2006
2006
  • A. Luque
  • MELECON - IEEE Mediterranean Electrotechnical…
  • 2006
  • Corpus ID: 24527900
We present in this article a view of the evolution of the photovoltaic industry. First the market evolution is forecasted on the… 
2005
2005
Tujuan diadakan penelitian ini adalah mengetahui faktor-faktor apa saja yang menyebabkan sulitnya berhenti merokok pada perokok…